| Advanced
wound care products present an attractive growth area within medical
devices.
Chronic wounds such as diabetic foot, venous and decubitus ulcers
affect 1-2 % of the population in industrialized countries and lead
to tremendous treatment costs accounting for billions of dollars
worldwide.. |
| Though the introduction of moist wound healing has revolutionized
wound treatment within the last 15 years, there are still many unmet
medical needs to be addressed. It is aim of Bayer Innovation to
develop new innovative treatment methods and solve major unmet medical
needs for difficult to heal chronic wounds. Project activities comprise
the development of new materials, drug equipped materials and pharmaceuticals
leveraging Bayer’s proprietary material and pharmaceutical
skills. |
 |